IMR Press / FBL / Volume 18 / Issue 2 / DOI: 10.2741/4142

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Review
The miRNAs in the pathgenesis of osteosarcoma
Show Less
1 Department of Orthopedics, Shaoxing People’s Hospital, Zhejiang 312000, China
2 Department of Orthopedics, The 306th Hospital of PLA, Beijing 100101, China
3 Department of Nephrology, Tongji Hospital of Tongji University, Shanghai 200065, China
4 Department of Orthopedics, Changhai Hospital of Second Military Medical University, Shanghai 200433, China
Front. Biosci. (Landmark Ed) 2013, 18(2), 788–794; https://doi.org/10.2741/4142
Published: 1 January 2013
(This article belongs to the Special Issue Pathogenesis and diagnostic modalities in cancer)
Abstract

Osteosarcoma is an aggressive sarcoma of the bone characterized by a high level of genetic instability and recurrent DNA deletions and amplifications. MicroRNAs (miRNAs) are non-coding small RNAs, usually 18–25 nucleotides in length, which repress translation and cleave mRNA by base-pairing to the 3 untranslated region of the target genes. miRNAs have demonstrated far-reaching effects on the cellular biology of development and cancer. Their role in osteosarcomagenesis remains largely unexplored. A number of reports have investigated the role of microRNAs in osteosarcoma. This review summeizes the recent research progress of miRNA in the osteosarcome.

Keywords
miRNAs
siRNAs
mRNA
Review
Share
Back to top